The value of follow-up after potentially curative treatment of breast cancer remains controversial. Recurrence-free women (n = 402) attending a breast clinic over a 3 month period were studied. The women attended 423 appointments, 412 of which were routine. Eleven were requested by the patient or general practitioner (interval appointments). All 11 interval and 19 of the routine appointments resulted in investigations for possible recurrence. Three (27%) interval appointments and four (1%) routine appointments resulted in the diagnosis of a recurrence (P < 10-5).
Introduction
Follow-up is standard practice in the aftercare of patients having surgical treatment for breast cancer. Very few recurrences are, however, potentially curable and it is probable that this practice has little effect on the subsequent course of the disease.' It is likely, though, that routine follow-up provides a framework for psychological support and is popular for this reason. 2'3 In this study, the effectiveness of follow-up in the detection of recurrence has been assessed. Also, patients' attitudes and the degree of social and domestic disruption caused by the follow-up process have been measured using a questionnaire.
Patients and methods
All patients receiving potentially curative treatment for breast cancer from one unit are followedup in two special weekly clinics. Routine follow-up appointments are given 3 monthly for the first year, 4 monthly for the next 2 years, 6 monthly for the next 2 years, and then annually for the next 5 years. An option ofdischarge from the clinic is given at 10 years.
An audit of these clinics was performed over a 3 month period. All patients who had received surgical treatment with or without adjuvant therapy and were free of recurrence at the start of the study were included. All suspected and confirmed recurrences during the study period were noted as was the method of presentation. Appointments initiated by patients or their general practitioners between routine visits were termed 'interval'.
Patients were asked to complete questionnaires during the clinic. The questions are shown in Table  I (a). Broadly, they deal with the effect of clinic attendance on social and domestic factors, attitudes to breast self-examination and with attitudes to the follow-up clinic.
Results
Four hundred and two study patients attended during the 3 month period. The median age of the women was 62 (range 23 -89) years and the median duration of follow-up was 2 years (range 1 month-17 years). The treatments and histological diagnoses are shown in Tables II and III . Two hundred and forty-one patients had negative axillary nodes, 103 patients had positive nodes and, in 48 patients, the nodal status was unknown.
The 402 patients attended 423 appointments during the 3 months of the study. Seventeen The initial treatment of the seven women with recurrent disease was by surgery alone in three cases and surgery with radiotherapy in four cases. Table I (b). Few had to take time off work (22%) or make special domestic arrangements (12%) to get to the clinic. Most used their own transport (64%) and had to travel less than 6 miles. The majority had been taught to examine their breast area (85%) and did so once a month or more (74%). Most patients preferred the idea of hospital follow-up to general practitioner follow-up (76%), and claimed to feel reassured and less anxious when they attended the clinic (81%).
Discussion
After potentially curative treatment of breast cancer, patients are followed-up for three main reasons. One of these, audit, has not so far been mentioned in this paper. This is clearly important in a disease in which treatment failures remain common. Whether out-patient follow-up is the only or best method for obtaining audit (or research) data will not be discussed further here. We would suggest, however, that patients are unlikely to regard their clinic visits as being principally of value for audit or research! Most doctors and patients regard the chief reason for follow-up to be the detection of recurrent disease. The major point at issue is whether there is any benefit in such detection before the patient becomes symptomatic. What evidence there is suggests that detection and treatment of asymptomatic disease results in no better survival than treatment of symptomatic recurrence."3'4 If this is so, detection of asymptomatic recurrence merely gives a patient more prolonged knowledge of treatment failure without any ultimate therapeutic benefit. It is clear from our results that 'interval' appointments yield a far higher proportion of recurrences than do routine follow-up appointments. This is in agreement with previous findings.25 The questionnaire results show that most patients examine their breast areas regularly and frequently. On these considerations alone, there would seem to be good reasons for discontinuing the practice of routine follow-up after potentially curative treatment of breast cancer. Women, however, prefer 'routine' to 'interval' appointments. They prefer conventional hospital follow-up to the idea ofgeneral practitioner followup which has been suggested by previous authors. 6 The majority feel reassured and less anxious when they attend the clinic. In addition, only a few have to take time off work or make special domestic arrangements to come to the clinic. Most women have to travel only a short distance to the clinic and most do so using their own transport. Thus our follow-up clinic appears to be popular and attendance causes little inconvenience.
We have not asked women whether they expect follow-up to increase their chances of survival but the popularity of the follow-up clinic suggests that this is probably their expectation. Clearly, however, it would not be supportive to these patients who are often distressed, to suggest that they may be able to follow the subsequent course of their disease as effectively as the doctors in the clinic.
The solution to this dilemma is not clear. An alternative to routine follow-up might be postoperative counselling with clinic visits only when requested by patients. A randomized trial comparing the value of routine and 'on demand' follow-up in patients having potentially curative treatment for breast cancer is probably timely.
